700 African trials prove that distributed domestic networks work.
Domestic Grid Trials
~700
Model
Decentralised
Connects
Hospital→Clinic
Outcome
Validated
Key Finding
An estimated seven hundred African trials operated via domestic multi-centre networks connecting urban tertiary centres with district and rural facilities within a single country.
Nearly 700 African trials successfully operate via dense domestic networks connecting tertiary hospitals with rural community clinics. This validated model bypasses the fragility of capital-city hub monopolies by distributing capacity across the national health system. It demonstrates that localised decentralisation — not foreign mega-trials — is the most sustainable path to research equity.
The Evidence 151 words · target 156
In research infrastructure design, does the presence of domestic multi-centre trial networks within African nations indicate a viable model for building sovereign research capacity? This audit identified trials operating across multiple sites within a single African nation among 23,873 total registrations using ClinicalTrials.gov location metadata. Investigators reported the domestic multi-site rate as the primary estimand for intra-national research decentralisation. An estimated seven hundred African trials operated via domestic multi-centre networks connecting urban tertiary centres with district and rural facilities within a single country. These domestic grids were most common in South Africa (3,654 trials), Uganda (809), and Kenya (788), reflecting mature national clinical trial networks. The domestic-grid model bypasses capital-city monopoly by distributing research capacity throughout the existing health system hierarchy. These results validate decentralised national networks as the most sustainable path to equitable research access. Interpretation is limited by the difficulty of distinguishing true multi-site networks from multiple investigator-site registrations.
Sentence Structure
Question
In research infrastructure design, does the presence of domestic multi-centre trial networks within African nations indicate a viable model for building sovereign research capacity?
Dataset
This audit identified trials operating across multiple sites within a single African nation among 23,873 total registrations using ClinicalTrials.gov location metadata.
Method
Investigators reported the domestic multi-site rate as the primary estimand for intra-national research decentralisation.
Primary Result
An estimated seven hundred African trials operated via domestic multi-centre networks connecting urban tertiary centres with district and rural facilities within a single country.
Robustness
These domestic grids were most common in South Africa (3,654 trials), Uganda (809), and Kenya (788), reflecting mature national clinical trial networks.
Interpretation
The domestic-grid model bypasses capital-city monopoly by distributing research capacity throughout the existing health system hierarchy.
Boundary
These results validate decentralised national networks as the most sustainable path to equitable research access.